מחיר חזוי לרווח: NanoVibronix (NAOV)

The expected P/E ratio for NanoVibronix, Inc. (NAOV), sourced from the GURU.Markets terminal, is based on acoustic wave technology for combating infections, with the 0.00 mark characterizing this parameter. Management is focusing on the expansion of portable wound-healing systems and insurance coverage. Development is further supplemented by the gradual market rollout of ultrasonic catheters for therapeutic impact.
פילוחי מדדים ואנליטיקה של חברת NanoVibronix, Inc. (NAOV)

Forward P/E determines investment attractiveness by comparing the current market value of a share with the projected net income for the upcoming period. By analyzing the NTM forward P/E of NanoVibronix, Inc. (NAOV), an investor assesses whether the growth premium for NanoVibronix, Inc. is justified against the backdrop of high clinical certification costs and intense pricing pressure from Asian ultrasound equipment manufacturers.